"Momentum continues to build across our business, with strong execution on our test menu, geographic expansion, and market extension programs all contributing to record first quarter revenue," said John Bishop, Cepheid's Chairman and Chief Executive Officer. "In the last 12 months, Cepheid has added eight tests to the international Xpert menu, including the milestone HIV Viral Load, HIV Qualitative and HCV Viral Load tests. Regardless of size, many of our international customers now have the capability to offer a broad molecular menu of HAI, critical infectious disease, sexual health and virology tests on a single accurate, efficient, scalable, and cost-effective platform."
Somebody likes CPHD...stock up $6/share today. Good 1st qtr numbers....revenue 24% above 1st qtr 2014.
ASM2015 website- "Exhibit your products and services to more than 8,000 high-level decision makers who not only spend close to 23% of their time in the Exhibit Hall, but rank learning about new products and methods as one of their top two reasons for attending the show"
5 years ago-poster called longnnlx--"This was also true when people stopped at NNLX's booth. Bret and Sergey both explained the technology with a freshness each time. People repeatedly were amazed at the simplicity. One guy came by who is huge in the microbiology world: he invented the agar everybody uses. He knew Bret and Sergey and there was #$%$-chat. Sergey was showing him something that took 7 hours and all he could say was "very impressive." Three people came by who were about Haiti water quality (two were from France). They stayed quite a long time asking every question in the book, also being quite amazed at the simplicity, effectiveness, and doability. "We'll be in touch." That happened alot. The contact machine had a scroll of tape of people whose badges Bret had swiped. And it was pretty cool that the info was also recorded on a thumb drive that plugged into the machine."
Famous last words I guess...."We'll be in touch." Sure was a whole lot of pumping going on by the hoe gamers on this board about how great it was to be exhibiting at the ASM. If they don't exhibit at the most important microbiology conference where will they exhibit instead......a boat show? So the marketing plan becomes a one-man road show? What are the distributors in Singapore & Saudi Arabia doing?
veteran12005 • May 19, 2009 1:25 PM
"I am at the ASM. It's going well, good discussions, lots of interest --- the NanoLogix personnel are healthy, good looking, and knowledgeable. Wait... we are the NanoLogix personnel and are naturally biased, so ignore that descriptive statement. Internet connections are spotty on the exhibition floor, the coffee is good but the food is not. BNP rules."
But, but, but....allegedly here he was checking in from the floor of the exhibition hall..."it's going well, good discussion, LOTS of interest". Now he says it's NOT cost effective? Does the BNP still rule? I guess he just got tired of all those microbiologists end-users walking past his booth.
Robert-A. Ollar, Ph.d
Sr. Scientist, Research & Development at NanoLogix
"He is a member of the WHO Global Stop TB Partnership and also serves as a Foreign Advisor for Mycobacterial and Nocardial Diseases at the Mahatma Gandhi Institute of Medical Sciences in Sevagram India."
This appears to me as a very well connected fellow at the WHO and in India."
Remember when the home gamers were pumping this guy's connections? He's now a member of the Pennsylvania Tick & Lyme Disease Task Force.
Can't give Barnhizer high marks for staff development & retention.
brookfieldbob wrote "Tedwardr, I asked, Brett said they were busy. I don't know what that signifies. "
It must signify he's not only the CEO but unless a replacement has been hired, he's the lab director, the SAB coordinator, the Operations Mgr., and also the water carrier.
Maybe Barnhizer made a few bucks by having the Youngstown bakers buy out the remaining two years on her contract. LOL Is she buying her culture plates from NNLX?
April 22, 2015 /PRNewswire/ -- Great Basin Scientific, Inc. (NASDAQ:GBSN and GBSNU), a molecular diagnostics company, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance for its molecular diagnostic test for Group B Streptococcus (GBS). This is Great Basin's second assay to be cleared by the FDA. The Company's first test, for Clostridium difficile, or C. diff, was approved in May 2012. Great Basin plans to launch the GBS assay commercially in the second quarter of 2015.
"Receiving FDA clearance for our GBS test represents a significant milestone for Great Basin, both as an expansion of our menu and as evidence of the company's ability to meet product deliverables," said Great Basin co-founder and Chief Executive Officer Ryan Ashton. "We are committed to delivering to hospitals and reference labs the products they need to quickly report accurate, definitive results, thus we are pleased with the on-time delivery of this test clearance. We look forward to growing our menu of tests over the next 18 months to further meet the need for easy-to-use and cost-effective molecular diagnostic testing."
Another entrant in the GBS testing space.
Almost 5 years ago-- “I don’t think we are going to be a small company for very long.”-Barnhizer
And yet "Curious" Brookfield Bob walks in on him thru the back door the other day...and the guy's pouring water! How many employees does this "big time" CEO have under his control these days? LOL